1. |
Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J, 2019, 53(5): 1900164.
|
2. |
He Y, Jiang B, Li LS, et al. Secondhand smoke exposure predicted COPD and other tobacco-related mortality in a 17 -year cohort study in China. Chest, 2012, 142(4): 909-918.
|
3. |
Tønnesen P. Smoking cessation and COPD. Eur Respir Rev, 2013, 22(127): 37-43.
|
4. |
Riesco JA, Alcázar B, Trigueros JA, et al. Active smoking and COPD phenotype: distribution and impact on prognostic factors. Int J Chron Obstruct Pulmon Dis, 2017, 12: 1989-1999.
|
5. |
徐海峰, 孙异锋, 林欢. 吸烟对慢性阻塞性肺疾病患者相关免疫炎性反应及肺功能的影响. 临床肺科杂志, 2020, 25(1): 58-61.
|
6. |
Bai JW, Chen XX, Liu S, et al. Smoking cessation affects the natural history of COPD. Int J Chron Obstruct Pulmon Dis, 2017, 12: 3323-3328.
|
7. |
罗勤利. 戒烟干预对不同风险程度慢性阻塞性肺疾病患者预后的影响对比. 临床肺科杂志, 2015, 20(6): 1076-1079.
|
8. |
Vogelmeier CF, Criner GJ, martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med, 2017, 195(5): 557-582.
|
9. |
Miravitlles M, Soler-cataluna JJ, Calle M, et al. Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol, 2017, 53(6): 324-335.
|
10. |
Eva AM, Onno CP, Geertjan W, et al. Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial. Eur Respir J, 2017, 49(6): 1700561.
|
11. |
Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev, 2018, 5(5): CD000146.
|
12. |
Tøttenborg SS, Thomsen RW, Johnsen SP, et al. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest, 2016, 150(3): 554-562.
|
13. |
Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev, 2013, 2013(5): CD000165.
|
14. |
杨添文, 杨丽芬, 任朝凤, 等. 督导戒烟及肺康复对慢阻肺患者肺功能及戒烟效果的影响. 昆明医科大学学报, 2020, 41(2): 104-109.
|
15. |
Cahill K, Lindson-hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, 2016, 2016(5): CD006103.
|
16. |
Howes S, Hartmann-Boyce J, Livingstone-Banks J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev, 2020, 4(4): CD000031.
|
17. |
Tøttenborg SS, Clark AJ, Thomsen RW, et al. Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1775-1781.
|
18. |
Chen ZM, Peto R, Zhou MG, et al; China Kadoorie Biobank (CKB) collaborative group. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet, 2015, 386(10002): 1447-1456.
|
19. |
Åberg J, Hasselgren M, Montgomery S, et al. Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2019, 14: 961-969.
|
20. |
Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2017, 23(2): 117-123.
|
21. |
Martínez-González C, Casanova C, De-torres JP, et al. Changes and clinical consequences of smoking cessation in patients with COPD: a prospective analysis from the chain cohort. Chest, 2018, 154(2): 274-285.
|
22. |
Dong XY, Wang L, Tao YX, et al. Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China. Int J Chron Obstruct Pulmon Dis, 2016, 12: 49-58.
|
23. |
Carrión Valero F, Paulos Dos Santos S, Celli BR. Smoking in COPD patients: a new clinical phenotype. Arch Bronconeumol, 2018, 54(5): 249-250.
|
24. |
Au DH, Bryson CL, Chien JW, et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med, 2009, 24(4): 457-463.
|
25. |
Godtfredsen NS, Vestbo J, Osler M, et al. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax, 2002, 57(11): 967-972.
|
26. |
Josephs L, Culliford D, Johnson M, et al. Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study. Eur Respir J, 2017, 49(5): 1602114.
|
27. |
Carreras G, Pistelli F, Falcone F, et al. Reduction of risk of dying from tobacco-related diseases after quitting smoking in italy. Tumori, 2015, 101(6): 657-663.
|
28. |
Liang WM, Chen JJ, Chang CH, et al. An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD. Quality of Life Research, 2008, 17(5): 793-800.
|
29. |
Zhou ZJ, Zhou AY, Zhao YY, et al. Evaluating the clinical COPD questionnaire: a systematic review. Respirology, 2017, 22(2): 251-262.
|
30. |
杜晓秋, 周军, 张秋娣. 不同评价指标在慢性阻塞性肺疾病患者综合评估中的应用. 中国全科医学, 2016, 19(5): 511-516.
|
31. |
Morishita-Katsu M, Nishimura K, Taniguchi H, et al. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?. Int J Chron Obstruct Pulmon Dis, 2016, 11: 1543-1551.
|
32. |
Varol Y, Ozacar R, Balci G, et al. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate copd severity and exacerbation rates. COPD, 2014, 11(2): 221-225.
|
33. |
蔡柏蔷. 放至全球而皆准的策略——我看《GOLD颁布的COPD全球策略(2011年修订版)》. 中国实用内科杂志, 2012, 32(5): 351-355.
|
34. |
刘贤兵, 李芳, 徐宁, 等. 戒烟干预对早期稳定期慢性阻塞性肺疾病患者气道局部免疫及生活质量的影响研究. 中国全科医学, 2021, 24(23): 2927-2939.
|